Live Breaking News & Updates on Vax Maker Yisheng Biopharma Co Ltd Chairman Zhang Yi 5th From Left Meets With Officials Of The Board Investments To Discuss Company 39s Investment Plans In Country Is Also Looking For Potential Local Partners Operate Philippines Photo Courtesy Boi Manila Said Tuesday Agency Met Chinese Global Pharmaceutical Firm Led Business Delegation As Group Possible Here Engaged Development And Commercialization Biotherapeutics Cancers Infectious Diseases Through Its Novel Pika Immunomodulation Technology Operating China

VAX MAKER. Yisheng Biopharma Co. Ltd. chairman Zhang Yi (5th from left) meets with officials of the Board of Investments to discuss the company's investment plans in the country. Yisheng is also looking for potential local partners to operate in the Philippines. (Photo courtesy of BOI) MANILA - The Board of Investments (BOI) said Tuesday the agency met with Chinese global pharmaceutical firm Yisheng Biopharma Co. Ltd. to discuss the company's investment plans in the Philippines. Yisheng chairman Zhang Yi led the business delegation to Manila as the group also met with possible local partners here. The Chinese pharmaceutical firm is engaged in the development and commercialization of biotherapeutics for cancers and infectious diseases through its novel PIKA immunomodulation technology. The firm is operating in China, Singapore, and the United States. "In the meeting, Chairman Yi and the Yisheng team shared that the company is preparing to initiate Phase III [of its] global ....

China , Yisheng , Zhejiang , Manila , Philippines , United-states , Zhang-yi , Ningxia , Singapore , Chinese , Evariste-cagatan , Corazon-halili-dichosa